Oxacillin
Oxacillin for Injection, USP (SDV) For Intramuscular or Intravenous Injection
Approved
Approval ID
195c2054-0746-421d-8b20-8c751bdd772b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 22, 2023
Manufacturers
FDA
Wockhardt USA LLC.
DUNS: 170508365
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Oxacillin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code64679-698
Application NumberANDA207147
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxacillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateNovember 22, 2023
FDA Product Classification
INGREDIENTS (2)
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT
OXACILLIN SODIUMActive
Quantity: 1 g in 20 mL
Code: G0V6C994Q5
Classification: ACTIM
Oxacillin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code64679-699
Application NumberANDA207147
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxacillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateNovember 22, 2023
FDA Product Classification
INGREDIENTS (2)
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT
OXACILLIN SODIUMActive
Quantity: 2 g in 20 mL
Code: G0V6C994Q5
Classification: ACTIM